Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

NYU Langone’s Laura and Isaac Perlmutter Cancer Center | Researchclopedia

Back to institutions

NYU Langone’s Laura and Isaac Perlmutter Cancer Center

New Yorkhealthcare

1,240

Works

112,138

Citations

152

h-index

Top Research Topics

Cancer Immunotherapy and Biomarkers Cancer Genomics and Diagnostics Lung Cancer Treatments and Mutations

Top Researchers

Harvey I. Pass NYU Langone Health

1,353 works121,813 citationsh-index: 153

Recent Research

Systemic Cysteine Elevation Sustains T-Cell Activation to Potentiate PD-1 Blockade

Xiaoshuang Wang,Zi Wang,et al.

20260 citations

Multiple Myeloma Research and Treatments

CAR-T cell therapy research

Immunotherapy and Immune Responses

Protein Degradation and Inhibitors

Acute Lymphoblastic Leukemia research

Lung Cancer Research Studies

Advanced Radiotherapy Techniques

Colorectal Cancer Treatments and Studies

Breast Cancer Treatment Studies

Douglas A. Levine Merck & Co., Inc., Rahway, NJ, USA (United States)

829 works107,134 citationsh-index: 127

Jeffrey S. Weber NYU Langone Health

1,156 works97,828 citationsh-index: 122

Richard B. Hayes Tufts University

1,049 works79,015 citationsh-index: 137

Kwok‐Kin Wong NYU Langone Health

1,655 works72,704 citationsh-index: 140

Gareth J. Morgan Hywel Dda University Health Board

1,929 works71,768 citationsh-index: 125

565eP Gender differences in quality of life, mental health, and survivorship experiences following lung cancer: A systematic literature review

N. Florez,Cecilia Pompili,et al.

20260 citations

Systematic Evaluation Defines the Limits of Ferroptosis in Cancer Therapy

Kenji M. Fujihara,Azmi Aziz,et al.

20260 citations

Safety and efficacy of pasritamig (PAS) + docetaxel (DOCE) in participants with metastatic castration-resistant prostate cancer (mcrPc): Initial results of a phase 1b study.

M. Patel,Russell K. Pachynski,et al.

20260 citations

Updated efficacy results from the phase 1 study of gotistobart (BNT316/ONC-392) in combination with lutetium Lu 177 vipivotide tetraxetan (Lu 177) in patients with metastatic castration-resistant prostate cancer (mCRPC).

David R. Wise,Tian Zhang,et al.

20260 citations

Study of NSD2 using a dTAG system reveals their molecular mechanism and oncogenic implications in t(4;14) multiple myeloma

Yubao Wang,Sanxiong Liu,et al.

20260 citations